期刊文献+

抗HBs-HBsAg复合物诱生体液免疫应答的研究 被引量:5

Humoral immune responses induced by anti HBs HBsAg immunogenic complexes (IC) in BALB/c mice
原文传递
导出
摘要 目的研究抗HBs-HBsAg复合物在BALB/c小鼠诱生体液免疫应答的特点。方法分别用鼠抗HBs-HBsAg免疫原性复合物(IC)或单独HBsAg免疫BALB/c小鼠(加或不加氢氧化铝),分析其诱生的抗HBsIgG效价及IgG亚类。结果用IC加氢氧化铝为佐剂免疫小鼠诱生的抗HBs中以IgG1亚类为主,而用HBsAg免疫鼠则以IgG2b亚类较高。IC不加氢氧化铝佐剂诱生的抗HBs中IgG1及IgG2a均高于单独HBsAg免疫鼠。研究还显示,抗HBsIgGFc段是巨噬细胞(MΦ)等抗原提呈细胞摄取IC的主要途径。结论抗HBs-HBsAg复合物免疫诱生的体液免疫应答较单独HBsAg免疫强。抗HBs主要通过Fc段的介导作用,改变了机体抗原提呈细胞对HBsAg的摄取、加工及抗原提呈,并可增强HBsAg的免疫原性。 Objective To study the anti HBs IgG and IgG subclasses induced by anti HBs HBsAg immunogenic complexes in BALB/c mice. Methods [WT5”BZ] Mouse anti HBs HBsAg complexes or goat anti HBs HBsAg complexes were separately used to immunize BALB/c mice,and the mice were boostered with IC or HBsAg alone three weeks later .ELISA assay was used to detect the anti HBs IgG and IgG subclasses. [WT5”HZ〗Results Immunization employing mouse anti HBs HBsAg complexes adsorbed to alum resulted in predominantly IgG1 response,whereas without adjuvant,both IgG1 and IgG2a antibodies were higher than those induced by HBsAg alone.Data also indicated that the Fc fragment of anti HBs IgG was necessary for increased uptake of anti HBs HBsAg complexes by antigen presenting cells. [WT5”HZ〗Conclusions Mouse anti HBs HBsAg complexes induced stronger humoral immune responses in BALB/c mice than that did by HBsAg alone. The Fc fragment of anti HBs mediated changes in uptake,processing and presentation of HBsAg by APC,which may increase the immunogenicity of HBsAg.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 1998年第4期331-335,共5页 Chinese Journal of Microbiology and Immunology
基金 国家863高科技计划资助
关键词 抗原抗体复合物 乙型肝炎 表面抗原 体液免疫 Antigen antibody complex HBsAg IgG Macrophage
  • 相关文献

参考文献4

二级参考文献3

  • 1闻玉梅,中华微生物学和免疫学杂志,1996年,16卷,155页
  • 2Wen Y M,Chin Med J,1994年,107卷,741页
  • 3单玉君,上海医科大学学报,1986年,13卷,29页

共引文献5

同被引文献39

  • 1霍龙飞,王莉林,卢景良.新城疫基因工程疫苗研究进展[J].生物技术,1995,5(5):1-5. 被引量:4
  • 2刘述先 李允鹤.日本血吸虫病免疫发病机制的研究现状.寄生虫病免疫学及免疫诊断[M].南京:江苏科学技术出版社,1991.175.
  • 3Wen YM, Qu D, Zhou SH. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B. Int Rev Immunol, 1999, 18: 251- 258.
  • 4Wen YM, Xiong SD, Zhang W. Solid matrix-antibody-antigen com-plex can clear viraemia and antigenaemia in persistent duck hepatitis B virus infection. J Gen Virol, 1994, 75 ( Pt 2): 335-339.
  • 5Zheng B J, Ng MH, He LF, et al. Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice. Vaccine, 2001, 19: 4219-4125.
  • 6Zheng B J, Zhou J, Qu D, et al. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat, 2004, 11:217-224.
  • 7Yao X, Zheng B, Zhou J, et al.Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and noncytolytic immune responses in hepatitis B patients. Vaccine, 2007,25:1771-1779.
  • 8Xu DZ, Huang KL, Zhao K, et al. Vaccination with recombinant HBsAg-HBIG complex in healthy adults. Vaccine, 2005, 23: 2658- 2664.
  • 9Xu DZ, Zhao K, Guo LM, et al. A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. PLoS One, 2008, 3: e2565.
  • 10Schuurhuis DH, Ioan-Facsinay A, Nagelkerken B, et al. Antigenantibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol, 2002,168: 2240-2246.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部